These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35369814)

  • 1. Role of lncRNA AGAP2-AS1 in Breast Cancer Cell Resistance to Apoptosis by the Regulation of MTA1 Promoter Activity.
    Wu M; Wen L; Zhou Y; Wu W
    Technol Cancer Res Treat; 2022; 21():15330338221085361. PubMed ID: 35369814
    [No Abstract]   [Full Text] [Related]  

  • 2. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.
    Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J
    J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M6A RNA Methylation-Mediated Dysregulation of AGAP2-AS1 Promotes Trastuzumab Resistance of Breast Cancer.
    Cai Y; Zheng H; Xu D; Xie J; Wang W; Liu Z; Zheng Z
    Pharmacology; 2024; 109(5):282-292. PubMed ID: 38744264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.
    Luo W; Li X; Song Z; Zhu X; Zhao S
    Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
    Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3.
    Chen J; Peng X; Dai Y
    Med Sci Monit; 2019 Jun; 25():4699-4704. PubMed ID: 31233485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4.
    Hui B; Ji H; Xu Y; Wang J; Ma Z; Zhang C; Wang K; Zhou Y
    Cell Death Dis; 2019 Feb; 10(3):207. PubMed ID: 30814490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
    Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
    J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA AGAP2-AS1 augments cell viability and mobility, and confers gemcitabine resistance by inhibiting miR-497 in colorectal cancer.
    Hong S; Yan Z; Song Y; Bi M; Li S
    Aging (Albany NY); 2020 Mar; 12(6):5183-5194. PubMed ID: 32202509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression analysis of vimentin and the related lncRNA network in breast cancer.
    Mohebi M; Ghafouri-Fard S; Modarressi MH; Dashti S; Zekri A; Kholghi-Oskooei V; Taheri M
    Exp Mol Pathol; 2020 Aug; 115():104439. PubMed ID: 32283061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Expression of Exosomal AGAP2-AS1 (AGAP2 Antisense RNA 1) In Breast Cancer Cells Inhibits Trastuzumab-Induced Cell Cytotoxicity.
    Zheng Z; Chen M; Xing P; Yan X; Xie B
    Med Sci Monit; 2019 Mar; 25():2211-2220. PubMed ID: 30910994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EIF4A3 stabilizes the expression of lncRNA AGAP2-AS1 to activate cancer-associated fibroblasts via MyD88/NF-κb signaling.
    Xu Q; Zhao T; Han H; Fan J; Xie W
    Thorac Cancer; 2023 Feb; 14(5):450-461. PubMed ID: 36541122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long non-coding RNA, ELFN1-AS1, sponges miR-1250 to upregulate MTA1 to promote cell proliferation, migration and invasion, and induce apoptosis in colorectal cancer.
    Zhai LQ; Wang XX; Qu CX; Yang LZ; Jia CM; Shi XC
    Eur Rev Med Pharmacol Sci; 2021 Jul; 25(14):4655-4667. PubMed ID: 34337713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer.
    Han J; Qu H; Han M; Ding Y; Xie M; Hu J; Chen Y; Dong H
    Oncogene; 2021 Jan; 40(4):833-847. PubMed ID: 33273726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing long non-coding RNA HNF1A-AS1 inhibits growth and resistance to TAM of breast cancer cells via the microRNA-363/SERTAD3 axis.
    Li Y; Liu L; Lv Y; Zhang Y; Zhang L; Yu H; Tian W; Zhang Z; Cui S
    J Drug Target; 2021 Aug; 29(7):742-753. PubMed ID: 33472456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA AGAP2-AS1 promotes the proliferation of glioma cells by sponging miR-15a/b-5p to upregulate the expression of HDGF and activating Wnt/β-catenin signaling pathway.
    Zheng Y; Lu S; Xu Y; Zheng J
    Int J Biol Macromol; 2019 May; 128():521-530. PubMed ID: 30684575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA.
    Bao G; Huang J; Pan W; Li X; Zhou T
    Cancer Med; 2020 Jan; 9(1):278-289. PubMed ID: 31701672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AGAP2-AS1: An Indispensable lncRNA in Tumors.
    Chen J; Wang B
    Mini Rev Med Chem; 2023; 23(3):336-342. PubMed ID: 35708074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA ARAP1-AS1 accelerates cell proliferation and migration in breast cancer through miR-2110/HDAC2/PLIN1 axis.
    Lu C; Wang X; Zhao X; Xin Y; Liu C
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32110804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SP1 induced long non-coding RNA AGAP2-AS1 promotes cholangiocarcinoma proliferation via silencing of CDKN1A.
    Ji H; Wang J; Lu B; Li J; Zhou J; Wang L; Xu S; Peng P; Hu X; Wang K
    Mol Med; 2021 Feb; 27(1):10. PubMed ID: 33522895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.